blog
NAMSA vs RQM Plus: Regulatory Consulting Comparison
Table of Contents
- NAMSA vs RQM Plus: Side-by-Side Service Overview
- FDA Regulatory Consulting for Medical Devices: Core Capabilities
- Medical Device Quality Management System Consulting
- Medical Device Regulatory Staffing Support: Flexibility and Scale
- Medical Device Regulatory Consultant Selection Criteria
- Real-World Implementation: What to Expect
- Making Your Final Decision
- Frequently Asked Questions
Last Updated: October 21, 2026
NAMSA vs RQM Plus: Side-by-Side Service Overview
Selecting a regulatory consulting partner through a regulatory consulting comparison affects your timeline, budget, and market access strategy. At E & E Medicals and Consulting, we understand the importance of selecting the right regulatory consulting partner.
Regulatory consulting comparison matters because the wrong partner can delay your FDA submission, miss compliance gaps, or leave you unprepared for FDA questions. The right partner accelerates your pathway and builds confidence in your quality management system before regulators see it.
NAMSA and RQM Plus are both established in medical device regulatory consulting, but differ in scope, team structure, engagement models, and depth of support. Understanding those differences helps you pick the right partner.
What Each Provider Specializes In
NAMSA brings decades of experience in FDA regulatory affairs, clinical evaluation, and biocompatibility testing, with a reputation for complex 510(k) and De Novo submissions.
RQM Plus focuses on regulatory consulting with expertise in quality management systems and FDA submissions, positioning itself as a simplified alternative to the largest firms with targeted support for 510(k), De Novo, and PMA pathways.
E & E Medicals and Consulting combines FDA regulatory expertise with a specialized focus on quality management and ISO compliance, working with companies from startups building their first QMS to mid-sized manufacturers strengthening compliance infrastructure.
Service Breadth and Geographic Reach
NAMSA operates globally with offices across North America, Europe, and Asia, well-suited for companies pursuing international market access alongside FDA clearance, offering device classification, biocompatibility, clinical evaluation, and regulatory submissions.
RQM Plus operates primarily in North America with a focused model centered on FDA submissions and quality system consulting. Their smaller footprint means faster decisions and direct access to senior consultants, though international expansion may require partnerships.
E & E Medicals and Consulting specializes in FDA regulatory expertise and quality management, with particular strength in ISO 13485 and QMSR requirements.
FDA Regulatory Consulting for Medical Devices: Core Capabilities
FDA regulatory consulting for medical devices is where these three firms overlap most directly. The difference isn't whether they can help you, it's how they prioritize your submission and what happens after you get clearance.
510(k), De Novo, and PMA Pathway Support
A 510(k) submission requires predicate selection, substantial equivalence arguments, and technical documentation that withstands FDA scrutiny.
RQM Plus also supports 510(k) submissions effectively, with particular strength helping smaller manufacturers navigate the process without unnecessary complexity or excessive documentation.
De Novo pathways, used when no predicate exists, require deeper regulatory strategy. NAMSA has demonstrated success here. RQM Plus handles De Novo work but sees fewer cases, meaning less institutional experience.
PMA submissions are the most complex FDA pathway, reserved for high-risk devices. NAMSA and RQM Plus both support PMA work, but NAMSA's scale gives them more active experience.
Clinical Evaluation and Technical Documentation
Clinical evaluation, the systematic review of existing data to demonstrate safety and effectiveness, is essential for most submissions. NAMSA handles this in-house, simplifying coordination but at full-service cost. RQM Plus typically partners with clinical consultants rather than maintaining that expertise internally.
Technical documentation quality determines whether the FDA accepts your submission on the first review cycle or sends deficiency letters, and attention to detail matters more than firm size.
Medical Device Quality Management System Consulting
Medical device quality management system consulting is where the three firms diverge most sharply. This is also where your choice has the longest-term impact on your business.
ISO 13485 and QMSR Implementation
ISO 13485 certification is mandatory for FDA-regulated devices and required for CE Mark in the EU.
NAMSA offers QMS consulting, but it's often bundled with larger regulatory submissions.
RQM Plus provides targeted QMS consulting, often paired with FDA submission work. They can help build or improve your system, though their focus tends to be compliance-focused rather than operationally integrated.
E & E Medicals and Consulting specializes in making QMS work in practice, transforming manual, fragmented systems into audit-ready operations that support product development.
Design Controls and Risk Management
Design controls ensure your device meets user needs and performs safely, while ISO 14971 risk management is the framework for identifying hazards and ensuring mitigation. Both are required by the FDA and essential for CE Mark.
NAMSA brings deep expertise here, particularly for complex devices where design controls must integrate with clinical data and manufacturing. RQM Plus supports design control implementation, though more consultatively than hands-on.
At E & E Medicals and Consulting, we treat design controls and risk management as foundational.
Medical Device Regulatory Staffing Support: Flexibility and Scale
Medical device regulatory staffing support addresses a real problem: you need regulatory expertise, but a full-time regulatory affairs manager may not make sense for a startup or smaller manufacturer, and you may need surge capacity when preparing a submission.
Temporary vs. Long-Term Engagement Models
NAMSA typically engages on project-based work for a specific submission or challenge, which works well if you know exactly what you need and for how long.
RQM Plus offers similar project-based models, more accessible to smaller companies, with pricing generally more transparent than the largest firms, though specifics depend on scope.
E & E Medicals and Consulting works with companies on both project and ongoing bases. For startups building their first QMS, we often start with intensive support over 3-6 months, then transition to periodic advisory work.
Scalability for Startups and Mid-Sized Manufacturers
Startups need someone who understands you're building everything from scratch, QMS, documentation practices, and regulatory strategy, and who won't overwhelm you with unnecessary complexity.
RQM Plus positions itself as startup-friendly and delivers, understanding lean operations and building a functional QMS without massive overhead. NAMSA can work with startups, but their scale sometimes means a more enterprise-focused approach.
For mid-sized manufacturers, the challenge is different: your people and systems may not be optimized for FDA requirements or international standards. You need a partner who works within your existing structure and improves it, not one who replaces it wholesale.
Medical Device Regulatory Consultant Selection Criteria
Choosing the right regulatory consulting partner requires evaluating more than credentials: how they actually work, whether they understand your situation, and whether the engagement model matches your needs.

Evaluating Expertise and Track Record
Ask about specific submissions they've supported, not just how many, but device types and pathways. A firm with extensive 510(k) experience may have limited De Novo or PMA depth.
Request references from companies in your device category. A consultant experienced with in vitro diagnostics may not fit implantable devices, since technical and clinical challenges differ.
Track record also includes FDA interactions: have they worked with your target review division, and do they understand current FDA thinking on your device category? Consultants who stay current with FDA communications anticipate questions and help you prepare stronger submissions.
Assessing Responsiveness and Team Structure
During initial conversations, notice how quickly they respond and how directly they engage. If you're talking to business development rather than the consultant who would actually work with you, that's a warning sign.
Ask about team structure: will you work with the same person throughout, or be handed off between consultants? Continuity matters, your consultant should understand your device, team, and business context deeply enough to anticipate problems.
Responsiveness during implementation is critical; waiting a week for answers slows your progress. E & E Medicals and Consulting prioritizes direct access and rapid turnaround.
Understanding Engagement Models and Support
How does the firm structure fees: project-based, time-and-materials, retainer, or hybrid? What's included, and what costs extra? Be wary of low initial fees that add significant charges as the project progresses.
What happens after your submission? Do they support you through FDA interactions, deficiency responses, and approval, or does the engagement end at submit?
Ask about ongoing support for post-market surveillance, design changes, and regulatory updates. Your consultant should be a long-term partner who helps you maintain compliance, not a one-time vendor.
Real-World Implementation: What to Expect
Understanding what the consulting engagement looks like helps you set realistic expectations and evaluate whether a firm's approach matches your needs.
Onboarding and Knowledge Transfer
The first 2-4 weeks should focus on your consultant learning your device, team, and regulatory strategy, including reviewing design documentation, understanding your manufacturing process, and identifying regulatory gaps.
Good consultants ask detailed questions and understand your situation before recommending solutions. If a consultant immediately tells you what to do without understanding your context, that's a red flag.
Knowledge transfer is critical: your team should learn from the consultant, not just receive deliverables, including why documentation is required, how the FDA will evaluate your submission, and how to build compliance into your processes.
Ongoing Support and Regulatory Changes
FDA guidance changes and new regulations take effect. Your consultant should keep you informed about changes affecting your device and regulatory strategy, which is where ongoing relationships matter more than one-time project engagements.
When you need to respond to FDA questions or handle a compliance issue, your consultant should be available quickly. Regulatory timelines don't accommodate slow response times.
Making Your Final Decision
| Selection Criterion | NAMSA | RQM Plus | E & E Medicals and Consulting |
|---|---|---|---|
| Depth of FDA expertise | Extensive, global network | Strong, focused on FDA | Specialized in FDA and quality systems |
| QMS and ISO 13485 focus | Included, not primary | Moderate focus | Primary specialization |
| Engagement flexibility | Project-based primarily | Project or ongoing | Flexible, scalable models |
| Best for startups | Yes, but enterprise-oriented | Yes, startup-friendly | Yes, startup and mid-market |
| International support | Strong across regions | Limited to North America | FDA and EU MDR expertise |
| Responsiveness | Depends on project size | Generally direct | Direct access priority |
| Post-market support | Available | Available | Available |
Your choice depends on your situation. If you need comprehensive biocompatibility testing alongside regulatory consulting, NAMSA's integrated model makes sense.
Consider where you are in your product lifecycle. Early-stage companies need help building systems and strategy; established manufacturers need help optimizing processes or navigating regulatory changes.
The regulatory consulting landscape includes many capable firms, but the best choice is the one that understands your device, your team, and your business context.
When you're ready to move forward, E & E Medicals and Consulting offers FDA regulatory expertise combined with deep specialization in quality management systems and ISO compliance.
Frequently Asked Questions
What is the main difference between NAMSA and RQM Plus for FDA regulatory consulting?
NAMSA operates as a large, diversified testing and consulting organization with broad laboratory and consulting capabilities across multiple industries. RQM Plus focuses specifically on regulatory consulting and quality management for medical device companies. The choice depends on whether you need integrated testing services or specialized regulatory guidance. Your company stage, device complexity, and budget also influence which provider aligns better with your regulatory consulting needs.
How should I evaluate a medical device regulatory consultant before hiring?
Ask for specific examples of submissions they've guided through FDA approval, including device classification, submission type, and approval timeline. Request references from companies similar to yours in size and device complexity. Confirm their team has current FDA knowledge by discussing recent guidance updates. Evaluate their responsiveness, clarity of communication, and whether they offer ongoing support beyond initial submission. Finally, understand their engagement model, whether they work on fixed projects, hourly basis, or retainer arrangements, to match your budget and timeline.
Which consulting partner is better for quality management system support, NAMSA or RQM Plus?
RQM Plus specializes in ISO 13485 and quality management system implementation for medical device companies, making it a strong choice if QMS is your primary need. NAMSA offers QMS consulting alongside broader services. If you need deep, focused expertise in building or remediating a quality management system, a specialist approach may provide more targeted guidance. If you need integrated testing, laboratory services, and QMS consulting together, NAMSA's broader capabilities might be more efficient.
What questions should I ask a regulatory consultant about their FDA expertise?
Ask how they stay current with FDA guidance changes, including specific examples from the past 12 months. Request details on their experience with your specific device classification and submission pathway. Ask about their track record with FDA meetings, Q-Submissions, and post-market surveillance. Inquire whether they have experience with your therapeutic area and any special FDA programs (like De Novo or Breakthrough Designation) relevant to your product. Finally, ask how they handle unexpected FDA feedback and what their contingency approach is if an initial submission receives a deficiency notice.